Structural Insights into the Molecular Design of Flutolanil Derivatives Targeted for Fumarate Respiration of Parasite Mitochondria

Autor: Teruki Honma, Tsuyoshi Sasaki, Emmanuel Oluwadare Balogun, Dan Sato, Junko Ohmori, Madoka Nagahama, Masatsugu Oda, Shigeru Matsuoka, Tomoo Shiba, Kiyoshi Kita, Shigeharu Harada, Masayuki Inoue, Daniel Ken Inaoka
Rok vydání: 2015
Předmět:
Models
Molecular

NADH-fumarate reductase system
Sus scrofa
Succinic Acid
Respiratory chain
Mitochondrion
fumarate respiration
Substrate Specificity
lcsh:Chemistry
Fumarates
Benzoquinones
Anilides
Enzyme Inhibitors
lcsh:QH301-705.5
Ascaris suum
Spectroscopy
chemistry.chemical_classification
biology
Electron Transport Complex II
General Medicine
respiratory system
Mitochondria
Computer Science Applications
Biochemistry
flutolanil
Oxidoreductases
crystal structure
Cell Respiration
antiparasitic agent
Article
Catalysis
Inorganic Chemistry
parasitic diseases
Animals
Parasites
Physical and Theoretical Chemistry
Binding site
Molecular Biology
Binding Sites
complex II
Organic Chemistry
biology.organism_classification
Antiparasitic agent
Enzyme
lcsh:Biology (General)
lcsh:QD1-999
chemistry
Structural biology
structure-based drug design
Phosphoenolpyruvate Carboxykinase (ATP)
Zdroj: International Journal of Molecular Sciences
Volume 16
Issue 7
Pages 15287-15308
International Journal of Molecular Sciences, Vol 16, Iss 7, Pp 15287-15308 (2015)
ISSN: 1422-0067
Popis: Recent studies on the respiratory chain of Ascaris suum showed that the mitochondrial NADH-fumarate reductase system composed of complex I, rhodoquinone and complex II plays an important role in the anaerobic energy metabolism of adult A. suum. The system is the major pathway of energy metabolism for adaptation to a hypoxic environment not only in parasitic organisms, but also in some types of human cancer cells. Thus, enzymes of the pathway are potential targets for chemotherapy. We found that flutolanil is an excellent inhibitor for A. suum complex II (IC50 = 0.058 μM) but less effectively inhibits homologous porcine complex II (IC50 = 45.9 μM). In order to account for the specificity of flutolanil to A. suum complex II from the standpoint of structural biology, we determined the crystal structures of A. suum and porcine complex IIs binding flutolanil and its derivative compounds. The structures clearly demonstrated key interactions responsible for its high specificity to A. suum complex II and enabled us to find analogue compounds, which surpass flutolanil in both potency and specificity to A. suum complex II. Structures of complex IIs binding these compounds will be helpful to accelerate structure-based drug design targeted for complex IIs.
Databáze: OpenAIRE